QUOTED. June 13, 2018. Nikolai Aljuri.
Executive Summary
Procept BioRobotics is seeking a unique Category I CPT code that would make it possible for its AquaBeam Aquablation device to be reimbursed at a higher rate than older prostate resection techniques. See what company founder and CEO Nikolai Aljuri said about it here.
"We decided to go with our own code because we knew that showing a benefit over the existing procedures would put us in a great position to have a better payment than all the existing technologies. That's something companies don't do; they just want to fit into an existing code, but once you do that you get boxed into a certain kind of payment. Here, given that we provide so many benefits, we were very confident that we should have our own code with a greater payment." –Nikolai Aljuri, CEO, Procept BioRobotics
- Find out more: Procept BioRobotics Believes Aquablation Could Dominate BPH Treatment…If It Gets Coverage
Click here for a free trial of Medtech Insight